Gwill York's most recent trade in Alto Neuroscience Inc. was a trade of 5,243 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alto Neuroscience Inc | Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 5,243 | 5,243 | - | - | Stock Option (right to buy) | |
| Alto Neuroscience Inc | Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 15,287 | 15,287 | - | - | Stock Option (right to buy) | |
| Alto Neuroscience Inc | Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 19,558 | 19,558 | - | - | Stock Option (right to buy) | |
| Alto Neuroscience Inc | Gwill York | Director | 06 Feb 2024 | 53,196 | 0 | - | - | Series A Preferred Stock | ||
| Alto Neuroscience Inc | Gwill York | Director | 06 Feb 2024 | 23,917 | 23,917 | - | - | Common Stock | ||
| Alto Neuroscience Inc | Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
| Alto Neuroscience Inc | Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 3,083 | 3,083 | - | - | Stock Option (right to buy) |